Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Moxifloxacin (0.5% w/v) + Dexamethasone (0.1% w/v)
Dosage Form : Eye Drops
Packaging Type : vial
Packaging : mono
Price : ₹130/-
Moxolunic D Eye Drops is a WHO-GMP certified otic formulation containing Moxifloxacin 0.5% w/v and Dexamethasone 0.1% w/v, developed to manage bacterial ear infections with associated inflammation.
Moxifloxacin, a fourth-generation fluoroquinolone antibiotic, targets a broad spectrum of Gram-positive and Gram-negative bacteria by inhibiting DNA gyrase, essential for bacterial replication. Dexamethasone, a potent corticosteroid, helps relieve inflammation, swelling, and discomfort in the Eye.
This combination is especially beneficial in treating conditions like otitis externa and post-surgical Eye infections, offering both antibacterial action and symptomatic relief. It is recommended to be used under the guidance of a healthcare professional to avoid resistance and ensure effective therapy.
Possible side effects include: Burning or stinging sensation in the ear Ear irritation or itching Rare allergic reactions like rash or swelling Temporary dizziness or discomfort If any severe reactions occur, such as severe pain or allergic reactions, discontinue use and seek immediate medical advice.
Moxolunic D Ear Drop is indicated for the treatment of: Otitis externa (outer ear canal infection) Otitis media (middle ear infection) Inflammation caused by ear infections
Consult a doctor before use if you have a history of ear problems, are pregnant, or breastfeeding.
Store in a cool, dry place, away from direct sunlight. Do not freeze. Keep out of reach of children.
Composition : Ofloxacin (0.3% w/v) + Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Moxifloxacin (0.5% w/v) + Prednisolone (1% w/v)
Composition : Moxifloxacin (0.5% w/v) + Difluprednate (0.05% w/v)
Composition : Moxifloxacin (5% w/v) + Betamethasone (0.1% w/v)
Composition : Ofloxacin (0.3% w/v) Eye Ear Drops
Composition : Flurbiprofen (0.03% w/v) + Gatifloxacin (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Moxifloxacin (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation